Literature DB >> 3137109

Characterization of the non enzymatic glycation of high density lipoprotein in diabetic patients.

C Calvo1, G Ponsin, F Berthezene.   

Abstract

In diabetic patients, hyperglycaemia results in the non enzymatic glycation of many proteins. We studied the glycation of HDL of patients with either type 1 or type 2 diabetes compared with that of control subjects. Although a basal glycation was detectable in HDL of normal individuals, this increased by about 400% in HDL of both groups of diabetic patients. The degree of HDL glycation was positively correlated with blood glucose concentration. All the HDL apoproteins were glycated but the glycation of apo A-I represented about 80% of the total HDL. These data were compared to those obtained in vitro after incubation of normal apo A-I either as free molecular species or as phospholipid/apo A-I complex, in the presence of glucose (0 to 80 mmol/l) at 37 degrees C. The resulting apo A-I glycation was dependent upon both time of incubation and glucose concentration and was largely increased in the presence of phospholipids. These data suggest that the in vivo glycation of HDL apoproteins might depend upon glucose concentration but might also be partly influenced by their lipid environment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137109

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  9 in total

Review 1.  The emerging role of HDL in glucose metabolism.

Authors:  Brian G Drew; Kerry-Anne Rye; Stephen J Duffy; Philip Barter; Bronwyn A Kingwell
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

2.  Glycation isotopic labeling with 13C-reducing sugars for quantitative analysis of glycated proteins in human plasma.

Authors:  Feliciano Priego-Capote; Alexander Scherl; Markus Müller; Patrice Waridel; Frédérique Lisacek; Jean-Charles Sanchez
Journal:  Mol Cell Proteomics       Date:  2009-11-06       Impact factor: 5.911

Review 3.  Why is HDL functionally deficient in type 2 diabetes?

Authors:  Anatol Kontush; M John Chapman
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

4.  Oxidized high-density lipoprotein is associated with increased plasma glucose in non-diabetic dyslipidemic subjects.

Authors:  Kazuhiko Kotani; Naoki Sakane; Masashi Ueda; Shinichi Mashiba; Yasuyuki Hayase; Kokoro Tsuzaki; Toshiyuki Yamada; Alan T Remaley
Journal:  Clin Chim Acta       Date:  2012-09-06       Impact factor: 3.786

Review 5.  Dysfunctional HDL as a diagnostic and therapeutic target.

Authors:  Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-13       Impact factor: 8.311

Review 6.  Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.

Authors:  Margo P Cohen; Fuad N Ziyadeh; Sheldon Chen
Journal:  J Lab Clin Med       Date:  2006-05

7.  GlyStruct: glycation prediction using structural properties of amino acid residues.

Authors:  Hamendra Manhar Reddy; Alok Sharma; Abdollah Dehzangi; Daichi Shigemizu; Abel Avitesh Chandra; Tatushiko Tsunoda
Journal:  BMC Bioinformatics       Date:  2019-02-04       Impact factor: 3.169

8.  Lack of Neuroprotective Effects of High-Density Lipoprotein Therapy in Stroke under Acute Hyperglycemic Conditions.

Authors:  David Couret; Cynthia Planesse; Jessica Patche; Nicolas Diotel; Brice Nativel; Steeve Bourane; Olivier Meilhac
Journal:  Molecules       Date:  2021-10-21       Impact factor: 4.411

9.  Plasma oxidized high-density lipoprotein and glycated apolipoprotein A-I concentrations in ST-segment elevation myocardial infarction patients with stress hyperglycaemia or high thrombus burden.

Authors:  Bing-Qiang Li; Yu-Cheng Zhong; Xiang Wang
Journal:  Ups J Med Sci       Date:  2018-09-27       Impact factor: 2.384

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.